Effects of estrogens on microtubule polymerization in vitro: correlation with estrogenicity. by Metzler, M & Pfeiffer, E
Effects of Estrogens on Microtubule
Polymerization in Vitro: Correlation
with Estrogenicity
Manfred Metzler and Erika Pfeiffer
Department of Chemistry, University of Kaiserslautern, Kaiserslautern, Germany
Several estrogens of diverse classes, namely stilbene estrogens, steroidal estrogens, phytoestrogens, mycoestrogens, lignans, and bisphenol A,
were studied for their ability to interfere with the assembly of microtubules under cell-free conditions. Inhibition of microtubules in intact cells may
lead to the induction of micronuclei and aneuploidy and thereby contribute to estrogen-mediated carcinogenesis. Diethylstilbestrol and various other
stilbene estrogens, as well as bisphenol A, were good inhibitors of microtubule polymerization whereas the othertested compounds were devoid of
this activity. Therefore, the ability of estrogenic substances to interact with microtubules does not correlate with the hormonal activity. - Environ
Health Perspect 103(Suppl 7):21-22 (1995)
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Introduction
Both natural estrogens, e.g., 170-estradiol
(E2), and synthetic estrogens, e.g., diethyl-
stilbestrol (DES), are associated with
human neoplasia (1). In experimental ani-
mals E2 and DES as well as several oftheir
analogs induce tumors in various tissues,
e.g., the kidney of the male Syrian golden
hamster (1,2). Moreover, primary cells
such as Syrian hamster embryo (SHE)
fibroblasts are morphologically and neo-
plastically transformed by E2 and DES
(3-5). In short-term assays, carcinogenic
estrogens fail to induce gene mutations and
DNA damage but lead to numerical and
structural chromosomal aberrations (6,7).
In particular, nonrandom aneuploidies
were observed in DES-transformed SHE
cells (8). Several laboratories have reported
that DES has colchicinelike effects, causing
inhibition ofmicrotubule (MT) polymeriza-
tion under cell-free conditions as well as dis-
ruption of the mitotic spindle and the
cytoplasmic MT complex in mammalian
cells (9-16). To clarify the question
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whether interaction with MTs is a property
shared by all estrogens, we have studied sev-
eral estrogens of diverse classes, namely
stilbene estrogens, steroidal estrogens, phy-
toestrogens, mycoestrogens, and lignans, for
their ability to interfere with MT assembly.
Bisphenol A, used for the manufacture of
polycarbonate plastics and recently identi-
fied as an environmental estrogen, has also
been included in thisstudy.
Methods
The MT polymerization assay used in our
laboratory has been described before (17).
Briefly, the test compound dissolved in
ethanol or dimethyl sulfoxide was added to
0.5 ml (final volume) of 10 piM MT pro-
teins from bovine brain in assembly buffer;
concentrations of the estrogens varied
between 10 and 100 pM; the concentra-
tion of the organic solvent was 2%.
Following an incubation period of20 min
at 370C, MT assembly was started by
adding 0.5 mM guanosine triphosphate,
and the increase in turbidity was measured
at 350 nm for 30 min. The control incuba-
tion containing all components except the
test compound was used as reference
(100% assembly). Depolymerization at 4°C
was carried out to confirm MT formation
and detect aggregation.
Results
The result of our study is summarized in
Table 1. All stilbene estrogens tested at
50-pM concentrations caused a 10 to 40%
inhibition of MT assembly. The data are
published in detail elsewhere (17). The
plastic estrogen bisphenol A proved to be a
Table 1. Ability of various estrogensa to inhibit micro-
tubule (MT) polymerization under cell-free conditions.
Inhibitors of No inhibition of
MT assembly MTassemblyb
E-DES Estrone, El
Z-DES 2-Hydroxy-El
3,3'-DES 4-Hydroxy-Ei
3,3',5,5'-Tetrafluoro-DES 171-Estradiol, E2
E,E-Dienestrol 2-Hydroxy-E2
Z,Z-Dienestrol 4-Hydroxy-E2
Indenestrol A 17a-Ethinyl-E2
Indenestrol B 11 3-Methoxy-17ct-
ethinyl-E2
Indanestrol Coumestrol, 50 pM
Erythro-hexestrol Genistein, 50 pM
Threo-hexestrol Daidzein, 50 pM
Bisphenol A Zearalenone, 50 pM
Zeranoe, 50 pM
Enterolactone
Enterodiol
Equol
'Nomenclature: DES, 3,4-di(4'-hydroxyphenyl)-hex-3-
ene; 3,3'-DES, 3,4-di(3'-hydroxyphenyl)-hex-3-ene;
3,3',5,5'-tetrafluoro-DES, 3,4-di(3',5'-difluoro-4'-
hydroxyphenyl)-hex-3-ene; dienestrol, 3,4-di(4'-
hydroxyphenyl)-hexa-2,4-diene; indenestrol A,
1-ethyl-2-(4'-hydroxyphenyl)-3-methyl-5-hydroxyindene;
indenestrol B, 1-methyl-2-(4'-hydroxyphenyl)-3-ethyl-6-
hydroxyindene; indanestrol, 1-ethyl-2-(4'-hydroxy-
phenyl)-3-methyl-5-hydroxyindane; hexestrol,
3,4-di(4'-hydroxyphenyl)-hexane; bisphenol A, 2,2-di(4'-
hydroxyphenyl)-propane. bAt 100-pM concentration
exceptwhen noted otherwise.
powerful inhibitor, exhibiting about half
the activity ofDES (18). In contrast, none
of the tested steroidal estrogens showed a
detectable inhibitory effect on MT poly-
merization even at 100-pM concentrations.
The same lack of effect was observed for
the phytoestrogens, mycoestrogens, and
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lignans listed in Table 1. However, several
ofthese compounds could not be tested at
100-jiM concentrations due to limitations
in solubility. The highest concentrations
tested without precipitation ofthe estrogens
are given in Table 1.
Discussion
When the inhibitory effects of the various
compounds for MT assembly are com-
pared with their known estrogen receptor
binding affinities, it becomes obvious that
no correlation between these two proper-
ties exists. Stilbene estrogens with very low
estrogen receptor binding, such as Z,Z-
dienestrol, indanestrol, or threo-hexestrol
(19), inhibit MT polymerization as well as
the strong estrogens DES, EE-dienestrol,
or erythro-hexestrol. On the other hand,
powerful steroidal estrogens such as E2,
17u-ethinyl-E2, and 11 3-methoxy-17x-
ethinyl-E2 (moxestrol) fail to inhibit MT
assembly, as do the moderately strong
phytoestrogens and mycoestrogens coume-
strol, genistein, and zearalenone.
Recent studies on the mechanism ofthe
DES-mediated inhibition ofMT polymer-
ization have shown that DES has two
binding sites on the tubulin heterodimer
(20), which is the major constituent of
MT proteins. One of the binding sites of
DES is related to that ofcolchicine, as both
compounds compete for this site. Binding
to this site probably causes the inhibition of
MT assembly. The other DES binding site
seems to have no relevance for MT poly-
merization, as it also binds E2, which dis-
plays no inhibitoryeffect.
It should be pointed out that the effect
of a compound on MT assembly observed
under cell-free conditons may be different
in intact cells where metabolism of the
estrogen can either diminish or enhance the
propensity for tubulin binding. An
increased inhibition ofMT assembly might
be expected for all compounds capable of
quinone formation, e.g., DES, indenestrol
A, the catechol estrogens 2- and 4-hydroxy-
E1 and E2, and possibly coumestrol, as
these reactive intermediates should cova-
lently bind to thiol groups of tubulin
essential for MT polymerization (21).
Furthermore, mechanisms other than inhi-
bition ofMT formation may be employed
by certain estrogens to cause chromosomal
nondisjunction or chromosomal breakage.
Examples are E2 and coumestrol (22): E2
appears to damage the kinetochore and
thereby impair the attachment of the
mitotic spindle to the chromatids, whereas
coumestrol seemingly has clastogenic effects
in mammalian cells. Therefore, the nonco-
valent interaction with tubulin and subse-
quent inhibition of MT assembly is only
one among several mechanisms whereby
estrogens can cause chromosomal damage.
This study has shown that the ability ofan
estrogenic substance to bind tubulin does
not correlate with the hormonal activity.
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